CHAPTER
4
36 Revision 07, August 2009
risk of adverse side effects such as changes in texture, and hypo
or hyperpigmentation. Adverse effects, should they occur, are
usually transient and should resolve themselves within a few
months.
In case any serious side effects occur, refer to Adverse Effects
Report (
6). If the effects match any of the criteria found there,
copy then fill out the form and send it by FAX or email to your
Radiancy Distributor and to Radiancy Ltd. within 48 hours of
noticing the effects.
Topical or general anesthesia is not required. Should the patient
feel discomfort, however, it may be recommended (e.g.: EMLA,
Elamax, Topicaine). If a topical anesthesia is applied, carefully
follow the instructions found in chapter
4.4.4.
4.4.
Pre-Treatment Preparations
4.4.1.
Prior to Treatment:
•
Have the patient sign an Informed Consent Form (ICF)
indicating that they consent and agree to the treatment
and that they understand and agree to the procedure and
its potential side effects.
o
It is very important to keep on file a hard copy of all
patient
records,
including
pre-treatment
photographs.
•
Thoroughly clean the area to degrease the skin and
remove any remains of cream, makeup, or topical
anesthesia. Do not use any flammable solutions, such as
alcohol or acetone to clean the treatment area.
•
Ensure that the skin surface is completely dry.
•
Cover moles and pigmented spots with non-flammable
white sticker or sceptic pencil.
Summary of Contents for Mistral
Page 1: ...User Manual August 2009 Revision 07...
Page 2: ......
Page 3: ...User Manual August 2009 Revision 07...
Page 8: ......
Page 89: ......
Page 90: ......